US Broker Ratings

Phathom Pharmaceuticals (PHAT) Stock Analysis: Evaluating a Potential 114% Upside in the Biotech Sector

For investors eyeing opportunities in the biotechnology sector, Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) presents an intriguing proposition. With a current market capitalization of approximately $863.63 million, Phathom Pharmaceuticals is making..

Exxon Mobil (XOM) Stock Analysis: Navigating Opportunities Amidst a Potential Downside Risk

Exxon Mobil Corporation (NYSE: XOM), a titan in the energy sector, continues to command significant attention from investors as it navigates the complexities of the global oil and gas market...

Health Catalyst, Inc (HCAT): Investor Outlook Reveals Over 100% Potential Upside

For investors seeking opportunities in the healthcare sector, Health Catalyst, Inc. (NASDAQ: HCAT) presents a compelling case. Despite its current challenges, the company offers significant potential upside, with analyst ratings..

Sanara MedTech Inc. (SMTI) Stock Analysis: A Promising 92.93% Potential Upside in the Healthcare Sector

Sanara MedTech Inc. (NASDAQ: SMTI) is a noteworthy player in the healthcare sector, especially for investors eyeing opportunities in medical instruments and supplies. With a market capitalization of $166.74 million,..

SANUWAVE Health, Inc. (SNWV) Investor Outlook: Exploring a Potential 156% Upside in the Medical Device Sector

SANUWAVE Health, Inc. (NASDAQ: SNWV) stands at the forefront of innovation in the medical device industry, with a focus on regenerative medicine. The company, headquartered in Eden Prairie, Minnesota, is..

Spok Holdings, Inc. (SPOK) Stock Analysis: A Look at the 11.15% Dividend Yield and 24.67% Upside Potential

Spok Holdings, Inc. (NASDAQ: SPOK), a key player in the healthcare communication solutions sector, presents an intriguing opportunity for investors with its robust dividend yield and potential price upside. Headquartered..

Nyxoah SA (NYXH) Stock Analysis: Exploring a 251% Potential Upside in the Promising Sleep Apnea Market

Nyxoah SA (NASDAQ: NYXH), a Belgium-based healthcare innovator, is making waves in the medical instruments and supplies industry with its cutting-edge solutions for obstructive sleep apnea (OSA). Despite its current..

Mereo BioPharma Group plc (MREO): Investor Outlook with a 639.75% Potential Upside

Mereo BioPharma Group plc (NASDAQ: MREO) is a name that has recently caught the attention of investors due to its striking potential for growth. With a staggering potential upside of..

Absci Corporation (ABSI)

⚠️ No article content returned.

..

XOMA Royalty Corporation (XOMA) Stock Analysis: Exploring a Potential 140% Upside for Investors

XOMA Royalty Corporation (NASDAQ: XOMA), a prominent player in the biotechnology sector, is drawing significant attention from investors with its impressive potential upside of 140.40%. Specializing in biotech royalty aggregation,..

Varex Imaging Corporation (VREX) Stock Analysis: Exploring a 65.92% Potential Upside in the Medical Devices Sector

Varex Imaging Corporation (NASDAQ: VREX) stands out in the healthcare sector, specifically within the medical devices industry, by offering a comprehensive range of X-ray imaging components for both medical and..

Outset Medical, Inc. (OM) Stock Analysis: Exploring a 213% Potential Upside in the Medical Devices Sector

Outset Medical, Inc. (NASDAQ: OM), a pioneering company in the healthcare sector, specifically within the medical devices industry, presents a fascinating case for investors with a notable potential upside of..

CytomX Therapeutics (CTMX) Stock Analysis: A Potential 165% Upside in the Biotech Arena

CytomX Therapeutics, Inc. (NASDAQ: CTMX) is drawing significant attention in the biotechnology sector, as its potential upside looms large at 165.15%. For investors looking to delve into the healthcare market,..

Arcturus Therapeutics Holdings (ARCT) Stock Analysis: Exploring a 255% Potential Upside

Arcturus Therapeutics Holdings (NASDAQ: ARCT), a biotechnology firm specializing in mRNA medicines, presents a unique investment opportunity with a staggering potential upside of 255.73%. Despite its current share price of..

Fulcrum Therapeutics, Inc. (FULC) Stock Analysis: A Biotech Gem with 174% Potential Upside

For investors eyeing a promising opportunity in the healthcare sector, Fulcrum Therapeutics, Inc. (NASDAQ: FULC) stands out as a compelling option. This clinical-stage biopharmaceutical company, headquartered in Cambridge, Massachusetts, is..

Alpha Teknova, Inc. (TKNO) Stock Analysis: A 224.91% Upside Potential in the Healthcare Sector

Alpha Teknova, Inc. (NASDAQ: TKNO), a key player in the healthcare sector, is drawing significant attention from investors due to its potential upside of 224.91%. Specializing in the production of..

TruBridge, Inc. (TBRG) Stock Analysis: Exploring a 50% Potential Upside in the Health Information Services Sector

For investors keen on the healthcare sector, TruBridge, Inc. (NASDAQ: TBRG) presents an intriguing opportunity with a significant potential upside of 50.11%. Operating within the Health Information Services industry, TruBridge..

Rigel Pharmaceuticals, Inc. (RIGL) Stock Analysis: Exploring a Potential 101% Upside in the Biotech Space

Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) is a compelling player in the biotechnology sector, piquing interest with its robust potential upside of 101.26%. This San Francisco-based company is dedicated to developing..

Evolent Health, Inc (EVH)

⚠️ No article content returned.

..

Viridian Therapeutics, Inc. (VRDN) Stock Analysis: 45% Upside Potential Amid Strong Buy Ratings

Individual investors looking to navigate the volatile waters of the biotechnology sector may find Viridian Therapeutics, Inc. (NASDAQ: VRDN) an intriguing opportunity, particularly with its significant upside potential of over..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds